Corvus hawaiiensis isolate bCorHaw1 chromosome 22, bCorHaw1.pri.cur, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Corvoidea; Corvidae; Corvus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036367.1.\nAssembly name: bCorHaw1.pri.cur\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGSY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 20-SEP-2021\nAssembly Method :: HiFiasm v. 0.15.4+galaxy; purge_dups v.\n 1.2.5+galaxy3; Bionano Solve v.\n 3.6.1+galaxy2; Salsa v. 2.3+galaxy0;\n gEVAL manual curation v. 2021-09-20; VGP\n pipeline v. 2.0\nAssembly Name :: bCorHaw1.pri.cur\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 29.61x\nSequencing Technology :: PacBio Sequel II HiFi; Illumina NovaSeq;\n Bionano Genomics Saphyr DLS; Arima\n Genomics Hi-C v2\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Corvus hawaiiensis Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
TAR DNA binding protein, transcript variant X2
TAR DNA binding protein, transcript variant X1
castor zinc finger 1, transcript variant X5
castor zinc finger 1, transcript variant X7
castor zinc finger 1, transcript variant X4
castor zinc finger 1, transcript variant X2
castor zinc finger 1, transcript variant X3
zinc finger protein castor homolog 1 isoform X2
zinc finger protein castor homolog 1 isoform X4
castor zinc finger 1, transcript variant X1
castor zinc finger 1, transcript variant X8
castor zinc finger 1, transcript variant X6
zinc finger protein castor homolog 1 isoform X1
zinc finger protein castor homolog 1 isoform X5
zinc finger protein castor homolog 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
DNA fragmentation factor subunit alpha, transcript variant X1
DNA fragmentation factor subunit alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
DNA fragmentation factor subunit alpha isoform X1
DNA fragmentation factor subunit alpha isoform X2
6-phosphogluconate dehydrogenase, decarboxylating
kinesin family member 1B, transcript variant X2
kinesin family member 1B, transcript variant X4
kinesin family member 1B, transcript variant X5
kinesin family member 1B, transcript variant X1
kinesin family member 1B, transcript variant X6
kinesin family member 1B, transcript variant X12
kinesin family member 1B, transcript variant X19
kinesin family member 1B, transcript variant X7
kinesin family member 1B, transcript variant X10
kinesin family member 1B, transcript variant X9
kinesin family member 1B, transcript variant X8
kinesin family member 1B, transcript variant X3
kinesin family member 1B, transcript variant X17
kinesin family member 1B, transcript variant X16
kinesin family member 1B, transcript variant X15
kinesin family member 1B, transcript variant X13
kinesin family member 1B, transcript variant X14
kinesin family member 1B, transcript variant X21
kinesin family member 1B, transcript variant X20
kinesin family member 1B, transcript variant X11
kinesin family member 1B, transcript variant X18
ubiquitination factor E4B, transcript variant X2
ubiquitination factor E4B, transcript variant X1
ubiquitin conjugation factor E4 B isoform X1
ubiquitin conjugation factor E4 B isoform X2
leucine zipper and CTNNBIP1 domain containing, transcript variant X2
nicotinamide nucleotide adenylyltransferase 1, transcript variant X1
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 isoform X1
nicotinamide nucleotide adenylyltransferase 1, transcript variant X3
nicotinamide nucleotide adenylyltransferase 1, transcript variant X2
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 isoform X3
nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 isoform X2
leucine zipper and CTNNBIP1 domain containing, transcript variant X1
catenin beta interacting protein 1, transcript variant X2
catenin beta interacting protein 1, transcript variant X1
catenin beta interacting protein 1, transcript variant X3
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta, transcript variant X8
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta, transcript variant X5
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta, transcript variant X6
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta, transcript variant X3
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta, transcript variant X4
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta, transcript variant X1
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta, transcript variant X2
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta, transcript variant X9
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta, transcript variant X7
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
transmembrane protein 201, transcript variant X3
transmembrane protein 201, transcript variant X2
transmembrane protein 201, transcript variant X1
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X1
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X2
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X3
splA/ryanodine receptor domain and SOCS box containing 1, transcript variant X4
SPRY domain-containing SOCS box protein 1
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase, transcript variant X2
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase, transcript variant X1
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase, transcript variant X3
GDH/6PGL endoplasmic bifunctional protein
solute carrier family 2, facilitated glucose transporter member 5-like, transcript variant X1
solute carrier family 2, facilitated glucose transporter member 5-like, transcript variant X2
solute carrier family 2, facilitated glucose transporter member 5-like
carbonic anhydrase 6, transcript variant X2
carbonic anhydrase 6, transcript variant X1
carbonic anhydrase 6, transcript variant X3
carbonic anhydrase 6, transcript variant X4
arginine-glutamic acid dipeptide repeats, transcript variant X6
arginine-glutamic acid dipeptide repeats, transcript variant X1
arginine-glutamic acid dipeptide repeats, transcript variant X5
arginine-glutamic acid dipeptide repeats, transcript variant X3
arginine-glutamic acid dipeptide repeats, transcript variant X4
arginine-glutamic acid dipeptide repeats, transcript variant X2
arginine-glutamic acid dipeptide repeats protein isoform X1
arginine-glutamic acid dipeptide repeats protein isoform X2
arginine-glutamic acid dipeptide repeats protein isoform X3
arginine-glutamic acid dipeptide repeats, transcript variant X7
arginine-glutamic acid dipeptide repeats protein isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sterile alpha motif domain containing 11, transcript variant X1
sterile alpha motif domain-containing protein 11 isoform X1
sterile alpha motif domain containing 11, transcript variant X2
sterile alpha motif domain containing 11, transcript variant X4
sterile alpha motif domain containing 11, transcript variant X3
sterile alpha motif domain-containing protein 11 isoform X2
sterile alpha motif domain-containing protein 11 isoform X4
sterile alpha motif domain-containing protein 11 isoform X3
sterile alpha motif domain containing 11, transcript variant X7
sterile alpha motif domain containing 11, transcript variant X5
sterile alpha motif domain containing 11, transcript variant X8
sterile alpha motif domain containing 11, transcript variant X6
sterile alpha motif domain-containing protein 11 isoform X5
sterile alpha motif domain-containing protein 11 isoform X6
NOC2 like nucleolar associated transcriptional repressor
kelch like family member 17, transcript variant X1
kelch like family member 17, transcript variant X2
kelch like family member 17, transcript variant X3
pleckstrin homology domain containing N1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
pleckstrin homology domain-containing family N member 1 isoform X1
pleckstrin homology domain containing N1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
pleckstrin homology domain-containing family N member 1 isoform X2
PPARGC1 and ESRR induced regulator, muscle 1, transcript variant X4
PPARGC1 and ESRR induced regulator, muscle 1, transcript variant X3
PPARGC1 and ESRR induced regulator, muscle 1, transcript variant X2
PPARGC1 and ESRR induced regulator, muscle 1, transcript variant X1
PGC-1 and ERR-induced regulator in muscle protein 1 isoform X4
PGC-1 and ERR-induced regulator in muscle protein 1 isoform X3
PGC-1 and ERR-induced regulator in muscle protein 1 isoform X2
PGC-1 and ERR-induced regulator in muscle protein 1 isoform X1
hes family bHLH transcription factor 4, transcript variant X1
hes family bHLH transcription factor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type 11-like
ring finger protein 223, transcript variant X1
ring finger protein 223, transcript variant X2
chromosome 22 C1orf159 homolog, transcript variant X2
chromosome 22 C1orf159 homolog, transcript variant X1
chromosome 22 C1orf159 homolog, transcript variant X3
chromosome 22 C1orf159 homolog, transcript variant X5
chromosome 22 C1orf159 homolog, transcript variant X4
uncharacterized protein C1orf159 homolog isoform X1
uncharacterized protein C1orf159 homolog isoform X3
uncharacterized protein C1orf159 homolog isoform X2
TNF receptor superfamily member 18, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 18 isoform X3
TNF receptor superfamily member 18, transcript variant X1
TNF receptor superfamily member 18, transcript variant X2
tumor necrosis factor receptor superfamily member 18 isoform X1
tumor necrosis factor receptor superfamily member 18 isoform X2
TNF receptor superfamily member 18, transcript variant X4
tumor necrosis factor receptor superfamily member 18 isoform X4
TNF receptor superfamily member 4, transcript variant X2
TNF receptor superfamily member 4, transcript variant X1
tumor necrosis factor receptor superfamily member 4 isoform X2
tumor necrosis factor receptor superfamily member 4 isoform X1
C1q and TNF related 12, transcript variant X1
C1q and TNF related 12, transcript variant X2
ubiquitin conjugating enzyme E2 J2, transcript variant X1
ubiquitin conjugating enzyme E2 J2, transcript variant X2
sodium channel epithelial 1 subunit delta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sodium channel epithelial 1 subunit delta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
amiloride-sensitive sodium channel subunit delta isoform X1
amiloride-sensitive sodium channel subunit delta isoform X2
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X7
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X4
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X6
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X5
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X2
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X3
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3, transcript variant X1
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X5
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X2
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X4
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X3
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 isoform X1
pseudouridine synthase like 1, transcript variant X1
pseudouridine synthase like 1, transcript variant X3
pseudouridine synthase like 1, transcript variant X2
tRNA pseudouridine synthase-like 1 isoform X3
tRNA pseudouridine synthase-like 1 isoform X1
tRNA pseudouridine synthase-like 1 isoform X2
lysophosphatidic acid receptor 6-like, transcript variant X3
lysophosphatidic acid receptor 6-like, transcript variant X1
lysophosphatidic acid receptor 6-like, transcript variant X2
integrator complex subunit 11, transcript variant X1
integrator complex subunit 11, transcript variant X2
integrator complex subunit 11 isoform X1
integrator complex subunit 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
integrator complex subunit 11 isoform X2
taste 1 receptor member 3, transcript variant X1
taste 1 receptor member 3, transcript variant X2
taste receptor type 1 member 3 isoform X1
taste receptor type 1 member 3 isoform X2
dishevelled segment polarity protein 1, transcript variant X2
dishevelled segment polarity protein 1, transcript variant X1
segment polarity protein dishevelled homolog DVL-1 isoform X2
segment polarity protein dishevelled homolog DVL-1 isoform X1
dishevelled segment polarity protein 1, transcript variant X3
segment polarity protein dishevelled homolog DVL-1 isoform X3
aurora kinase A interacting protein 1, transcript variant X2
aurora kinase A interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
39S ribosomal protein L20, mitochondrial
von Willebrand factor A domain containing 1, transcript variant X2
von Willebrand factor A domain containing 1, transcript variant X1
von Willebrand factor A domain-containing protein 1 isoform X1
von Willebrand factor A domain-containing protein 1 isoform X2
ATPase family AAA domain-containing protein 3
transmembrane protein 240, transcript variant X3
transmembrane protein 240, transcript variant X2
transmembrane protein 240, transcript variant X1
uncharacterized LOC125337111, transcript variant X4
uncharacterized LOC125337111, transcript variant X2
uncharacterized LOC125337111, transcript variant X3
uncharacterized LOC125337111, transcript variant X1
uncharacterized protein LOC125337111 isoform X2
uncharacterized protein LOC125337111 isoform X1
SSU72 homolog, RNA polymerase II CTD phosphatase
RNA polymerase II subunit A C-terminal domain phosphatase SSU72
fibronectin type III domain containing 10
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: fibronectin type III domain-containing protein 10
Golgi integral membrane protein 4-like, transcript variant X1
Golgi integral membrane protein 4-like, transcript variant X3
Golgi integral membrane protein 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
Golgi integral membrane protein 4-like isoform X1
Golgi integral membrane protein 4-like isoform X3
Golgi integral membrane protein 4-like isoform X2
uncharacterized LOC125337116, transcript variant X3
uncharacterized LOC125337116, transcript variant X2
uncharacterized LOC125337116, transcript variant X1
MIB E3 ubiquitin protein ligase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
MIB E3 ubiquitin protein ligase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
MIB E3 ubiquitin protein ligase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
E3 ubiquitin-protein ligase MIB2 isoform X1
E3 ubiquitin-protein ligase MIB2 isoform X2
MIB E3 ubiquitin protein ligase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
E3 ubiquitin-protein ligase MIB2 isoform X3
cyclin-dependent kinase 11B, transcript variant X7
cyclin-dependent kinase 11B, transcript variant X6
cyclin-dependent kinase 11B, transcript variant X5
cyclin-dependent kinase 11B, transcript variant X4
cyclin-dependent kinase 11B, transcript variant X2
cyclin-dependent kinase 11B, transcript variant X3
cyclin-dependent kinase 11B, transcript variant X1
solute carrier family 35 member E2B, transcript variant X1
solute carrier family 35 member E2B, transcript variant X2
solute carrier family 35 member E2B, transcript variant X4
solute carrier family 35 member E2B, transcript variant X3
G protein subunit beta 1, transcript variant X6
G protein subunit beta 1, transcript variant X5
G protein subunit beta 1, transcript variant X4
G protein subunit beta 1, transcript variant X3
G protein subunit beta 1, transcript variant X1
G protein subunit beta 1, transcript variant X2
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
uncharacterized LOC125337036, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC125337036, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
transmembrane protein 52, transcript variant X1
transmembrane protein 52, transcript variant X2
cilia and flagella associated protein 74, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cilia and flagella associated protein 74, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cilia and flagella associated protein 74, transcript variant X3
cilia and flagella associated protein 74, transcript variant X1
cilia and flagella associated protein 74, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cilia- and flagella-associated protein 74 isoform X4
cilia- and flagella-associated protein 74 isoform X3
cilia- and flagella-associated protein 74 isoform X2
cilia- and flagella-associated protein 74 isoform X1
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X2
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X3
gamma-aminobutyric acid type A receptor subunit delta, transcript variant X1
gamma-aminobutyric acid receptor subunit delta isoform X1
gamma-aminobutyric acid receptor subunit delta isoform X2
gamma-aminobutyric acid receptor subunit delta isoform X3
protein kinase C zeta, transcript variant X2
protein kinase C zeta, transcript variant X1
protein kinase C zeta, transcript variant X3
FA core complex associated protein 20, transcript variant X1
FA core complex associated protein 20, transcript variant X3
FA core complex associated protein 20, transcript variant X2
Fanconi anemia core complex-associated protein 20 isoform X1
Fanconi anemia core complex-associated protein 20 isoform X2
retention in endoplasmic reticulum sorting receptor 1
phospholipase C eta 2, transcript variant X2
phospholipase C eta 2, transcript variant X18
phospholipase C eta 2, transcript variant X3
phospholipase C eta 2, transcript variant X4
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X13
phospholipase C eta 2, transcript variant X7
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X5
phospholipase C eta 2, transcript variant X6
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X4
phospholipase C eta 2, transcript variant X17
phospholipase C eta 2, transcript variant X15
phospholipase C eta 2, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
phospholipase C eta 2, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
phospholipase C eta 2, transcript variant X5
phospholipase C eta 2, transcript variant X1
phospholipase C eta 2, transcript variant X8
phospholipase C eta 2, transcript variant X12
phospholipase C eta 2, transcript variant X13
phospholipase C eta 2, transcript variant X10
phospholipase C eta 2, transcript variant X11
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X3
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X8
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X10
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X9
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X11
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X12
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X6
phospholipase C eta 2, transcript variant X9
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 isoform X7
probable glutamate receptor, transcript variant X2
probable glutamate receptor, transcript variant X1
membrane metalloendopeptidase like 1, transcript variant X3
membrane metalloendopeptidase like 1, transcript variant X2
membrane metalloendopeptidase like 1, transcript variant X1
membrane metallo-endopeptidase-like 1 isoform X1
membrane metallo-endopeptidase-like 1 isoform X2
membrane metallo-endopeptidase-like 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
histone-lysine N-methyltransferase PRDM16 isoform X1
histone-lysine N-methyltransferase PRDM16 isoform X2
histone-lysine N-methyltransferase PRDM16 isoform X3
uncharacterized LOC125337047, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125337047, transcript variant X1
uncharacterized LOC125337047, transcript variant X2
histone-lysine N-methyltransferase PRDM16 isoform X4
Rho guanine nucleotide exchange factor 16
multiple EGF like domains 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
multiple EGF like domains 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
multiple epidermal growth factor-like domains protein 6 isoform X1
multiple epidermal growth factor-like domains protein 6 isoform X2
tumor protein p63 regulated 1 like, transcript variant X1
tumor protein p63 regulated 1 like, transcript variant X2
tumor protein p63 regulated 1 like, transcript variant X3
tumor protein p63-regulated gene 1-like protein
WD repeat containing, antisense to TP73, transcript variant X2
WD repeat containing, antisense to TP73, transcript variant X1
WD repeat-containing protein WRAP73 isoform X2
WD repeat-containing protein WRAP73 isoform X1
tumor protein p73, transcript variant X2
tumor protein p73, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
coiled-coil domain-containing protein 27
leucine-rich repeat-containing protein 47
DNA fragmentation factor subunit beta, transcript variant X1
DNA fragmentation factor subunit beta isoform X1
DNA fragmentation factor subunit beta, transcript variant X2
DNA fragmentation factor subunit beta isoform X2
uncharacterized LOC125337175, transcript variant X2
uncharacterized LOC125337175, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X3
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X4
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X2
voltage-gated potassium channel subunit beta-2 isoform X2
voltage-gated potassium channel subunit beta-2 isoform X3
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X5
voltage-gated potassium channel subunit beta-2 isoform X4
potassium voltage-gated channel subfamily A regulatory beta subunit 2, transcript variant X1
voltage-gated potassium channel subunit beta-2 isoform X1
chromodomain helicase DNA binding protein 5, transcript variant X2
chromodomain helicase DNA binding protein 5, transcript variant X1
chromodomain helicase DNA binding protein 5, transcript variant X3
chromodomain helicase DNA binding protein 5, transcript variant X4
chromodomain-helicase-DNA-binding protein 5 isoform X2
chromodomain-helicase-DNA-binding protein 5 isoform X1
chromodomain-helicase-DNA-binding protein 5 isoform X3
ring finger protein 207, transcript variant X1
ring finger protein 207, transcript variant X2
isoprenylcysteine carboxyl methyltransferase
protein-S-isoprenylcysteine O-methyltransferase
acyl-CoA thioesterase 7, transcript variant X5
acyl-CoA thioesterase 7, transcript variant X2
acyl-CoA thioesterase 7, transcript variant X1
acyl-CoA thioesterase 7, transcript variant X4
acyl-CoA thioesterase 7, transcript variant X3
cytosolic acyl coenzyme A thioester hydrolase isoform X2
cytosolic acyl coenzyme A thioester hydrolase isoform X1
cytosolic acyl coenzyme A thioester hydrolase isoform X4
cytosolic acyl coenzyme A thioester hydrolase isoform X3
cytosolic acyl coenzyme A thioester hydrolase isoform X5
tumor necrosis factor receptor superfamily member 25
pleckstrin homology and RhoGEF domain containing G5, transcript variant X1
pleckstrin homology and RhoGEF domain containing G5, transcript variant X2
pleckstrin homology and RhoGEF domain containing G5, transcript variant X3
pleckstrin homology and RhoGEF domain containing G5, transcript variant X5
pleckstrin homology and RhoGEF domain containing G5, transcript variant X4
pleckstrin homology domain-containing family G member 5 isoform X2
pleckstrin homology domain-containing family G member 5 isoform X1
pleckstrin homology domain-containing family G member 5 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and BTB domain containing 48
DnaJ heat shock protein family (Hsp40) member C11, transcript variant X1
DnaJ heat shock protein family (Hsp40) member C11, transcript variant X2
dnaJ homolog subfamily C member 11 isoform X1
dnaJ homolog subfamily C member 11 isoform X2
calmodulin binding transcription activator 1, transcript variant X1
calmodulin binding transcription activator 1, transcript variant X9
calmodulin binding transcription activator 1, transcript variant X3
calmodulin binding transcription activator 1, transcript variant X2
calmodulin binding transcription activator 1, transcript variant X10
calmodulin binding transcription activator 1, transcript variant X8
calmodulin binding transcription activator 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calmodulin binding transcription activator 1, transcript variant X7
calmodulin binding transcription activator 1, transcript variant X6
calmodulin-binding transcription activator 1 isoform X1
calmodulin-binding transcription activator 1 isoform X9
calmodulin binding transcription activator 1, transcript variant X4
calmodulin-binding transcription activator 1 isoform X4
calmodulin-binding transcription activator 1 isoform X2
calmodulin-binding transcription activator 1 isoform X6
calmodulin-binding transcription activator 1 isoform X10
calmodulin-binding transcription activator 1 isoform X3
calmodulin-binding transcription activator 1 isoform X8
calmodulin-binding transcription activator 1 isoform X7
calmodulin-binding transcription activator 1 isoform X5
calmodulin binding transcription activator 1, transcript variant X11
calmodulin-binding transcription activator 1 isoform X11
calmodulin binding transcription activator 1, transcript variant X13
calmodulin binding transcription activator 1, transcript variant X12
calmodulin-binding transcription activator 1 isoform X12
calmodulin-binding transcription activator 1 isoform X13
period circadian regulator 3, transcript variant X1
period circadian protein homolog 3 isoform X1
period circadian regulator 3, transcript variant X2
period circadian protein homolog 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
tumor necrosis factor receptor superfamily member 9
Parkinsonism associated deglycase, transcript variant X2
Parkinsonism associated deglycase, transcript variant X3
Parkinsonism associated deglycase, transcript variant X1
ERBB receptor feedback inhibitor 1, transcript variant X1
ERBB receptor feedback inhibitor 1, transcript variant X2
solute carrier family 45 member 1, transcript variant X1
solute carrier family 45 member 1, transcript variant X13
solute carrier family 45 member 1, transcript variant X12
solute carrier family 45 member 1, transcript variant X10
solute carrier family 45 member 1, transcript variant X6
solute carrier family 45 member 1, transcript variant X7
solute carrier family 45 member 1, transcript variant X5
solute carrier family 45 member 1, transcript variant X9
solute carrier family 45 member 1, transcript variant X11
solute carrier family 45 member 1, transcript variant X2
solute carrier family 45 member 1, transcript variant X3
solute carrier family 45 member 1, transcript variant X8
solute carrier family 45 member 1, transcript variant X4
proton-associated sugar transporter A isoform X3
proton-associated sugar transporter A isoform X1
proton-associated sugar transporter A isoform X2
28S ribosomal protein S16, mitochondrial
transmembrane protein 51, transcript variant X4
transmembrane protein 51, transcript variant X3
transmembrane protein 51, transcript variant X2
transmembrane protein 51, transcript variant X1
kazrin, periplakin interacting protein, transcript variant X1
kazrin, periplakin interacting protein, transcript variant X2
kazrin, periplakin interacting protein, transcript variant X3
uncharacterized LOC125337093, transcript variant X1
uncharacterized LOC125337093, transcript variant X2
PR domain zinc finger protein 2 isoform X1
PR domain zinc finger protein 2 isoform X2
leucine-rich repeat-containing protein 38
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
dehydrogenase/reductase 3, transcript variant X1
dehydrogenase/reductase 3, transcript variant X2
short-chain dehydrogenase/reductase 3 isoform X1
dehydrogenase/reductase 3, transcript variant X3
dehydrogenase/reductase 3, transcript variant X4
short-chain dehydrogenase/reductase 3 isoform X2
vacuolar protein sorting 13 homolog D, transcript variant X1
vacuolar protein sorting 13 homolog D, transcript variant X6
vacuolar protein sorting 13 homolog D, transcript variant X3
vacuolar protein sorting 13 homolog D, transcript variant X5
vacuolar protein sorting 13 homolog D, transcript variant X2
vacuolar protein sorting 13 homolog D, transcript variant X4
vacuolar protein sorting-associated protein 13D isoform X6
vacuolar protein sorting-associated protein 13D isoform X3
vacuolar protein sorting-associated protein 13D isoform X5
vacuolar protein sorting-associated protein 13D isoform X2
vacuolar protein sorting-associated protein 13D isoform X4
vacuolar protein sorting-associated protein 13D isoform X1
tumor necrosis factor receptor superfamily member 1B
TNF receptor superfamily member 8, transcript variant X2
TNF receptor superfamily member 8, transcript variant X3
TNF receptor superfamily member 8, transcript variant X1
tumor necrosis factor receptor superfamily member 8 isoform X2
tumor necrosis factor receptor superfamily member 8 isoform X1
TNF receptor superfamily member 8, transcript variant X4
tumor necrosis factor receptor superfamily member 8 isoform X3
migration and invasion inhibitory protein
migration and invasion-inhibitory protein
procollagen-lysine,2-oxoglutarate 5-dioxygenase 1, transcript variant X1
procollagen-lysine,2-oxoglutarate 5-dioxygenase 1, transcript variant X2
procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 isoform X1
procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 isoform X2
uncharacterized protein KIAA2013 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 24% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: natriuretic peptides A-like
chloride voltage-gated channel 6, transcript variant X1
chloride voltage-gated channel 6, transcript variant X2
H(+)/Cl(-) exchange transporter 6 isoform X1
H(+)/Cl(-) exchange transporter 6 isoform X2
methylenetetrahydrofolate reductase, transcript variant X4
methylenetetrahydrofolate reductase, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
methylenetetrahydrofolate reductase, transcript variant X9
methylenetetrahydrofolate reductase, transcript variant X5
methylenetetrahydrofolate reductase, transcript variant X3
methylenetetrahydrofolate reductase, transcript variant X2
methylenetetrahydrofolate reductase, transcript variant X1
methylenetetrahydrofolate reductase isoform X1
methylenetetrahydrofolate reductase isoform X3
methylenetetrahydrofolate reductase isoform X2
methylenetetrahydrofolate reductase, transcript variant X7
methylenetetrahydrofolate reductase, transcript variant X6
methylenetetrahydrofolate reductase isoform X4
methylenetetrahydrofolate reductase isoform X5
uncharacterized protein C1orf167 homolog
angiotensin II receptor associated protein
type-1 angiotensin II receptor-associated protein
mitotic arrest deficient 2 like 2, transcript variant X3
mitotic arrest deficient 2 like 2, transcript variant X1
mitotic spindle assembly checkpoint protein MAD2B isoform X1
mitotic arrest deficient 2 like 2, transcript variant X2
mitotic spindle assembly checkpoint protein MAD2B isoform X2
F-box only protein 44-like, transcript variant X3
F-box only protein 44-like, transcript variant X2
F-box only protein 44-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
dispatched RND transporter family member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
UbiA prenyltransferase domain containing 1, transcript variant X2
UbiA prenyltransferase domain containing 1, transcript variant X1
UbiA prenyltransferase domain containing 1, transcript variant X4
UbiA prenyltransferase domain containing 1, transcript variant X3
ubiA prenyltransferase domain-containing protein 1 isoform X1
ubiA prenyltransferase domain-containing protein 1 isoform X2
mechanistic target of rapamycin kinase, transcript variant X1
mechanistic target of rapamycin kinase, transcript variant X2
serine/threonine-protein kinase mTOR isoform X1
serine/threonine-protein kinase mTOR isoform X2
angiopoietin like 7, transcript variant X1
angiopoietin like 7, transcript variant X2
angiopoietin-related protein 7 isoform X2
angiopoietin-related protein 7 isoform X1
homeodomain interacting protein kinase 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
homeodomain-interacting protein kinase 4
uncharacterized LOC125337016, transcript variant X4
uncharacterized LOC125337016, transcript variant X2
uncharacterized LOC125337016, transcript variant X1
uncharacterized LOC125337016, transcript variant X3
Y-box binding protein 1, transcript variant X2
Y-box binding protein 1, transcript variant X1
Y-box binding protein 1, transcript variant X3
cell division cycle 42, transcript variant X2
cell division cycle 42, transcript variant X1
cell division cycle 42, transcript variant X4
cell division cycle 42, transcript variant X3
cell division control protein 42 homolog isoform X1
cell division control protein 42 homolog isoform X2
cell division control protein 42 homolog isoform X3
Wnt family member 4, transcript variant X3
Wnt family member 4, transcript variant X2
Wnt family member 4, transcript variant X1
zinc finger and BTB domain containing 40
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 7 bases in 4 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 7 bases in 4 codons; substituted 6 bases at 6 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger and BTB domain-containing protein 40
complement C1q subcomponent subunit C-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
lactamase beta like 1, transcript variant X1
lactamase beta like 1, transcript variant X2
putative beta-lactamase-like 1 isoform X1
putative beta-lactamase-like 1 isoform X2
lactamase beta like 1, transcript variant X3
lactamase beta like 1, transcript variant X4
putative beta-lactamase-like 1 isoform X3
putative beta-lactamase-like 1 isoform X4
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
EF-hand domain-containing protein D2-like, transcript variant X2
forkhead-associated domain-containing protein 1-like isoform X2
EF-hand domain-containing protein D2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
EF-hand domain-containing protein D2-like, transcript variant X1
forkhead-associated domain-containing protein 1-like isoform X3
forkhead-associated domain-containing protein 1-like isoform X1
EF-hand domain-containing protein D2-like, transcript variant X4
forkhead-associated domain-containing protein 1-like isoform X4
EF-hand domain-containing protein D2-like, transcript variant X5
EF-hand domain-containing protein D2-like isoform X5
EF-hand domain-containing protein D2-like, transcript variant X6
EF-hand domain-containing protein D2-like isoform X6
chymotrypsin-C-like, transcript variant X1
chymotrypsin-C-like, transcript variant X2
chymotrypsin-C-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
DnaJ heat shock protein family (Hsp40) member C16
serine/threonine-protein kinase PINK1, mitochondrial
family with sequence similarity 43 member B
mitochondrial E3 ubiquitin protein ligase 1
mitochondrial ubiquitin ligase activator of NFKB 1
calcium/calmodulin dependent protein kinase II inhibitor 1
calcium/calmodulin-dependent protein kinase II inhibitor 1
von Willebrand factor A domain containing 5B1, transcript variant X1
von Willebrand factor A domain containing 5B1, transcript variant X3
von Willebrand factor A domain containing 5B1, transcript variant X2
von Willebrand factor A domain-containing protein 5B1 isoform X1
von Willebrand factor A domain-containing protein 5B1 isoform X2
von Willebrand factor A domain-containing protein 5B1 isoform X3
ATP-dependent RNA helicase DDX19B, transcript variant X1
ATP-dependent RNA helicase DDX19B isoform X1
ATP-dependent RNA helicase DDX19B, transcript variant X2
ATP-dependent RNA helicase DDX19A isoform X2
phospholipase A2, membrane associated-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
basic phospholipase A2 sphenotoxin subunit B-like, transcript variant X4
basic phospholipase A2 sphenotoxin subunit B-like isoform X2
basic phospholipase A2 sphenotoxin subunit B-like, transcript variant X2
basic phospholipase A2 sphenotoxin subunit B-like, transcript variant X3
basic phospholipase A2 sphenotoxin subunit B-like, transcript variant X1
small nuclear ribonucleoprotein-associated protein B'-like isoform X1
transmembrane and coiled-coil domains 4, transcript variant X1
transmembrane and coiled-coil domains 4, transcript variant X3
transmembrane and coiled-coil domains 4, transcript variant X4
transmembrane and coiled-coil domains 4, transcript variant X2
transmembrane and coiled-coil domain-containing protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
neuroblastoma suppressor of tumorigenicity 1
mitochondrial contact site and cristae organizing system subunit 10
capping actin protein of muscle Z-line subunit beta, transcript variant X1
capping actin protein of muscle Z-line subunit beta, transcript variant X2
F-actin-capping protein subunit beta isoform X2
F-actin-capping protein subunit beta isoform X1
lysosomal amino acid transporter 1 homolog
aldo-keto reductase family 7 member A2, transcript variant X2
aflatoxin B1 aldehyde reductase member 2 isoform X2
aldo-keto reductase family 7 member A2, transcript variant X1
aflatoxin B1 aldehyde reductase member 2 isoform X1
MRT4 homolog, ribosome maturation factor
ER membrane protein complex subunit 1, transcript variant X1
ER membrane protein complex subunit 1, transcript variant X2
ER membrane protein complex subunit 1, transcript variant X3
ER membrane protein complex subunit 1 isoform X1
ER membrane protein complex subunit 1 isoform X2
ER membrane protein complex subunit 1 isoform X3
ubiquitin protein ligase E3 component n-recognin 4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase UBR4
aldehyde dehydrogenase 4 family member A1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
aldehyde dehydrogenase 4 family member A1, transcript variant X1
delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial isoform X1
delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC125337236, transcript variant X1
uncharacterized LOC125337236, transcript variant X2
Rho guanine nucleotide exchange factor 10 like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 4 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: rho guanine nucleotide exchange factor 10-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
collagen alpha-1(III) chain-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
collagen alpha-1(III) chain-like, transcript variant X2
BUB3-interacting and GLEBS motif-containing protein ZNF207-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
protein-arginine deiminase type-1-like, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 6 bases in 5 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 6 bases in 5 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein-arginine deiminase type-3-like
protein-arginine deiminase type-1-like, transcript variant X1
succinate dehydrogenase complex iron sulfur subunit B
succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial
uncharacterized LOC125336976, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC125336976, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
uncharacterized LOC125336976, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
uncharacterized LOC125336976, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC125336976, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC125336976, transcript variant X2
uncharacterized LOC125336976, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC125336976, transcript variant X4
uncharacterized protein LOC125336976 isoform X3
uncharacterized protein LOC125336976 isoform X4
uncharacterized protein LOC125336976 isoform X7
uncharacterized protein LOC125336976 isoform X2
uncharacterized protein LOC125336976 isoform X6
uncharacterized protein LOC125336976 isoform X1
uncharacterized protein LOC125336976 isoform X5
uncharacterized protein LOC125336976 isoform X8
ATPase cation transporting 13A2, transcript variant X1
ATPase cation transporting 13A2, transcript variant X2
ATPase cation transporting 13A2, transcript variant X4
ATPase cation transporting 13A2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ATPase cation transporting 13A2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ATPase cation transporting 13A2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
polyamine-transporting ATPase 13A2 isoform X1
polyamine-transporting ATPase 13A2 isoform X2
polyamine-transporting ATPase 13A2 isoform X3
polyamine-transporting ATPase 13A2 isoform X4
microfibril associated protein 2, transcript variant X2
microfibril associated protein 2, transcript variant X1
microfibril associated protein 2, transcript variant X3
ciliary rootlet coiled-coil, rootletin, transcript variant X4
ciliary rootlet coiled-coil, rootletin, transcript variant X2
ciliary rootlet coiled-coil, rootletin, transcript variant X3
ciliary rootlet coiled-coil, rootletin, transcript variant X5
ciliary rootlet coiled-coil, rootletin, transcript variant X1
adaptin ear-binding coat-associated protein 2
SUZ RNA binding domain containing 1, transcript variant X2
SUZ RNA binding domain containing 1, transcript variant X1
SUZ RNA binding domain containing 1, transcript variant X4
SUZ RNA binding domain containing 1, transcript variant X3
SUZ RNA binding domain containing 1, transcript variant X6
SUZ RNA binding domain containing 1, transcript variant X5
SUZ domain-containing protein 1 isoform X2
SUZ domain-containing protein 1 isoform X1
SUZ domain-containing protein 1 isoform X4
SUZ domain-containing protein 1 isoform X3
SUZ domain-containing protein 1 isoform X6
SUZ domain-containing protein 1 isoform X5
ciliogenesis and planar polarity effector complex subunit 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
ciliogenesis and planar polarity effector complex subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ciliogenesis and planar polarity effector complex subunit 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
ciliogenesis and planar polarity effector complex subunit 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
ciliogenesis and planar polarity effector 2 isoform X1
ciliogenesis and planar polarity effector 2 isoform X3
ciliogenesis and planar polarity effector 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 111 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
heat shock protein family B (small) member 7
zinc finger and BTB domain containing 17
zinc finger and BTB domain-containing protein 17
spen family transcriptional repressor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
spen family transcriptional repressor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
spen family transcriptional repressor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
spen family transcriptional repressor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
uncharacterized LOC125337119, transcript variant X1
uncharacterized LOC125337119, transcript variant X2
uncharacterized LOC125337119, transcript variant X3
uncharacterized LOC125337119, transcript variant X4
filamin binding LIM protein 1, transcript variant X3
filamin binding LIM protein 1, transcript variant X4
filamin binding LIM protein 1, transcript variant X2
filamin binding LIM protein 1, transcript variant X5
filamin binding LIM protein 1, transcript variant X1
filamin binding LIM protein 1, transcript variant X6
pleckstrin homology and RUN domain containing M2, transcript variant X2
pleckstrin homology and RUN domain containing M2, transcript variant X1
pleckstrin homology domain-containing family M member 2 isoform X2
pleckstrin homology domain-containing family M member 2 isoform X1
protein DDI1 homolog 2, transcript variant X1
regulatory solute carrier protein family 1 member 1 isoform X1
protein DDI1 homolog 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
protein DDI1 homolog 2, transcript variant X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit
dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: kinesin-like protein KIF17
SH2 domain containing 5, transcript variant X1
SH2 domain containing 5, transcript variant X3
SH2 domain containing 5, transcript variant X2
heterochromatin protein 1 binding protein 3, transcript variant X1
heterochromatin protein 1 binding protein 3, transcript variant X3
heterochromatin protein 1 binding protein 3, transcript variant X2
heterochromatin protein 1-binding protein 3 isoform X2
heterochromatin protein 1-binding protein 3 isoform X1
heterochromatin protein 1-binding protein 3 isoform X3
eukaryotic translation initiation factor 4 gamma 3, transcript variant X9
eukaryotic translation initiation factor 4 gamma 3, transcript variant X3
eukaryotic translation initiation factor 4 gamma 3, transcript variant X5
eukaryotic translation initiation factor 4 gamma 3, transcript variant X2
eukaryotic translation initiation factor 4 gamma 3, transcript variant X1
eukaryotic translation initiation factor 4 gamma 3, transcript variant X4
eukaryotic translation initiation factor 4 gamma 3, transcript variant X11
eukaryotic translation initiation factor 4 gamma 3, transcript variant X12
eukaryotic translation initiation factor 4 gamma 3, transcript variant X10
eukaryotic translation initiation factor 4 gamma 3, transcript variant X8
eukaryotic translation initiation factor 4 gamma 3, transcript variant X7
eukaryotic translation initiation factor 4 gamma 3, transcript variant X6
eukaryotic translation initiation factor 4 gamma 3, transcript variant X13
eukaryotic translation initiation factor 4 gamma 3, transcript variant X16
eukaryotic translation initiation factor 4 gamma 3, transcript variant X14
eukaryotic translation initiation factor 4 gamma 3 isoform X10
eukaryotic translation initiation factor 4 gamma 3 isoform X9
eukaryotic translation initiation factor 4 gamma 3 isoform X8
eukaryotic translation initiation factor 4 gamma 3 isoform X7
eukaryotic translation initiation factor 4 gamma 3 isoform X6
eukaryotic translation initiation factor 4 gamma 3 isoform X4
eukaryotic translation initiation factor 4 gamma 3 isoform X3
eukaryotic translation initiation factor 4 gamma 3 isoform X2
eukaryotic translation initiation factor 4 gamma 3 isoform X5
eukaryotic translation initiation factor 4 gamma 3 isoform X1
eukaryotic translation initiation factor 4 gamma 3, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
eukaryotic translation initiation factor 4 gamma 3 isoform X11
endothelin converting enzyme 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
endothelin converting enzyme 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 64 samples with support for all annotated introns
endothelin converting enzyme 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
endothelin converting enzyme 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
endothelin converting enzyme 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
endothelin converting enzyme 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
endothelin converting enzyme 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
endothelin converting enzyme 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
endothelin-converting enzyme 1 isoform X1
endothelin-converting enzyme 1 isoform X2
endothelin-converting enzyme 1 isoform X3
alkaline phosphatase, biomineralization associated, transcript variant X2
alkaline phosphatase, biomineralization associated, transcript variant X1
alkaline phosphatase, tissue-nonspecific isozyme isoform X1
alkaline phosphatase, tissue-nonspecific isozyme isoform X2
RAP1 GTPase activating protein, transcript variant X1
RAP1 GTPase activating protein, transcript variant X6
RAP1 GTPase activating protein, transcript variant X4
RAP1 GTPase activating protein, transcript variant X3
RAP1 GTPase activating protein, transcript variant X5
RAP1 GTPase activating protein, transcript variant X2
rap1 GTPase-activating protein 1 isoform X2
rap1 GTPase-activating protein 1 isoform X1
ubiquitin specific peptidase 48, transcript variant X2
ubiquitin specific peptidase 48, transcript variant X1
ubiquitin specific peptidase 48, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 48 isoform X2
ubiquitin carboxyl-terminal hydrolase 48 isoform X1
ubiquitin carboxyl-terminal hydrolase 48 isoform X3
ubiquitin specific peptidase 48, transcript variant X5
ubiquitin specific peptidase 48, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 48 isoform X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 5 codons; deleted 15 bases in 13 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 5 codons; deleted 15 bases in 13 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: basement membrane-specific heparan sulfate proteoglycan core protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 6 bases in 6 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 6 bases in 6 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 362-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
LOW QUALITY PROTEIN: polyhomeotic-like protein 2
solute carrier family 2 member 1, transcript variant X1
solute carrier family 2 member 1, transcript variant X2
solute carrier family 2, facilitated glucose transporter member 1 isoform X2
solute carrier family 2, facilitated glucose transporter member 1 isoform X1
zinc finger MYND domain-containing protein 12
phosphopantothenoylcysteine synthetase, transcript variant X1
phosphopantothenoylcysteine synthetase, transcript variant X3
phosphopantothenate--cysteine ligase isoform X1
phosphopantothenate--cysteine ligase isoform X3
phosphopantothenoylcysteine synthetase, transcript variant X2
phosphopantothenate--cysteine ligase isoform X2
coiled-coil domain containing 30, transcript variant X2
coiled-coil domain containing 30, transcript variant X1
coiled-coil domain-containing protein 30 isoform X1
coiled-coil domain-containing protein 30 isoform X2
coiled-coil domain containing 30, transcript variant X3
coiled-coil domain containing 30, transcript variant X5
coiled-coil domain containing 30, transcript variant X4
coiled-coil domain containing 30, transcript variant X6
coiled-coil domain-containing protein 30 isoform X3
coiled-coil domain-containing protein 30 isoform X4
uncharacterized LOC125337025, transcript variant X1
uncharacterized LOC125337025, transcript variant X2